International Federation of Associations of Pharmaceutical Physicians and Pharmaceutical MedicineVulnerability, social value and the equitable sharing of benefits from research: beyond the placebo and access debates
The vulnerability of research participants is a critical topic for the 2024 revision of the Declaration of Helsinki, with the […]
The vulnerability of research participants is a critical topic for the 2024 revision of the Declaration of Helsinki, with the […]
The World Medical Association’s Declaration of Helsinki is in the process of being revised. The following amendments are recommended to […]
This volume captures the recent changes and evolution in ethics in research involving humans and provides future directions to achieve […]
Scientific research is essential to improve the health and well-being of people around the world, and to respond to health […]
Clinical scientists and ethicists have reviewed the unique situation of a large number of clinical trials in Ukraine, Russia, and […]
This paper discusses the effects of armed conflict, economic sanctions, and natural catastrophes on ongoing clinical trials. We suggest that
This position paper is intended to provide recommendations that will help lay the foundation for best practices for medical science […]
Gene therapy orphan medicinal products constitute a unique group of new drugs which in case of hereditary diseases are usually […]
